The US FDA has approved a new weight-loss pill developed by Eli Lilly and Company, marking a significant step forward in oral therapies and increasing competition with Novo Nordisk
Warsito D, Sjstrm S, Andersson S, Larsson O, Sehat B
Ingredients Water, Centella Asiatica Extract (29.2%), Butylene Glycol, Propanediol, Niacinamide (20, 000ppm), Glycerin, Diethoxyethyl Succinate, Panthenol, Sodium Hyaluronate, Allantoin, Glutathione (1, 000ppm), Sodium Polyacryloyldimethyl Taurate, Glyceryl Acrylate/Acrylic Acid Copolymer, Nelumbo Nucifera Extract, Artemisia Annua Extract, Oryza Sativa (Rice) Extract, Saccharomyces Ferment, Solanum Melongena (Eggplant) Fruit Extract, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Hydrolyzed Collagen, Squalane, Beta-Glucan, Dipropylene Glycol, Hippophae Rhamnoides Fruit Extract, Adenosine, Madecassic Acid, Asiaticoside, Asiatic Acid, Caprylic/Capric Triglyceride, Hydrogenated Lecithin, Glyceryl Stearate, Cholesterol, Styrene/Acrylates Copolymer, Cellulose Gum, Xanthan Gum, Inulin, Cellulose, Glucose, Fructose, Citric Acid, Disodium EDTA, Hydroxyacetophenone, 1-2-Hexanediol, Ethylhexylglycerin, Dipotassium Glycyrrhizate, Sodium Citrate The manufacturer is responsible for the products ingredients
This avoids adding bulk to a stomach that is already emptying slowly, which is a primary contributor to the bloating sensation GLP-1 users experience
Preliminary results also indicate that opi3 reacts similarly to cho2 in response to choline supplementation (data not shown)
